The survey results are in – hundreds of market access execs shared their predictions for and frustrations with the development of managed markets in the U.S. Get feedback to some of the industry’s most burning questions, such as:
- Who are the key stakeholders pharma needs to engage above all others?
- Where budgets will increase over the next 2 years
- Whether pharma is really getting its timing right with pricing and reimbursement
Download the results here. (Source: eyeforpharma, 2016)